Skip to Content
Merck
All Photos(1)

Key Documents

SML0530

Sigma-Aldrich

Clonixin

≥98% (HPLC)

Synonym(s):

2-[(3-Chloro-2-methylphenyl)amino]-3-pyridinecarboxylic acid, CBA 93626, Chlonixin, Clonixic acid, Clonixin, Clonixine, NSC 335505, Sch 10304

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C13H11ClN2O2
CAS Number:
Molecular Weight:
262.69
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77

Pricing and availability is not currently available.

Quality Level

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 15 mg/mL, clear

storage temp.

room temp

SMILES string

Cc1c(Cl)cccc1Nc2ncccc2C(O)=O

InChI

1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18)

InChI key

CLOMYZFHNHFSIQ-UHFFFAOYSA-N

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
Z720542Z720526B7407
feature

with cap

feature

-

feature

with cap

feature

with cap

material

high-density polyethylene cap, round transparent PETG bottle

material

high-density polyethylene cap, round transparent PETG bottle

material

PETG bottle, clear bottle, high-density polyethylene cap, round bottle, wide-mouth bottle

material

polypropylene cap, polypropylene screw closure, round bottle, translucent high-density polyethylene

capacity

10 mL

capacity

20 mL

capacity

-

capacity

30 mL

joint

Joints threaded neck (20-415)

joint

Joints threaded neck (20-415)

joint

Joints threaded neck (20-415)

joint

Joints threaded neck (20)

packaging

pack of 20 ea

packaging

pack of 20 ea

packaging

pack of 20 ea

packaging

pack of 12 ea

Biochem/physiol Actions

Clonixin is a non steroidal anti inflammatory drug (NSAID) with analgesic properties. The compound has been reported to block prostaglandin synthesis, and to block inward calcium currents.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Precautionary Statements

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Need A Sample COA?

This is a sample Certificate of Analysis (COA) and may not represent a recently manufactured lot of this specific product.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

L W Kissell et al.
Journal of dairy science, 95(12), 7151-7157 (2012-10-09)
The objective of this study was to determine if the plasma pharmacokinetics and milk elimination of flunixin (FLU) and 5-hydroxy flunixin (5OH) differ following intramuscular and subcutaneous injection of FLU compared with intravenous injection. Twelve lactating Holstein cows were used
D Goerigk et al.
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere, 40(2), 112-118 (2012-04-25)
Malignant catarrhal fever (MCF) is a worldwide occurring sporadic disease of cloven-hoofed animals. For the first time, this case report describes clinical and pathological as well as histopathological findings in an alpaca suffering from MCF caused by ovine herpesvirus 2.
David Douglas et al.
Journal of food protection, 75(7), 1270-1277 (2012-09-18)
β-Lactam antibiotics are the most commonly used drugs on dairy farms. β-Lactam residues in milk are kept out of the human milk supply with good agricultural practices and mandatory truck screening performed by the dairy industry under Appendix N of
Jeffrey M B Musser et al.
Journal of the American Veterinary Medical Association, 242(2), 205-208 (2013-01-02)
To investigate the disposition kinetics of flunixin meglumine when administered IV to budgerigars (Melopsittacus undulatus) and Patagonian conures (Cyanoliseus patagonus). Prospective cohort study. 8 adult Patagonian conures and 24 adult budgerigars. Injectable flunixin meglumine (50 mg/mL) was diluted to 10
J H Foreman et al.
Equine veterinary journal. Supplement, (43)(43), 17-20 (2013-03-02)
There are no refereed controlled documentations of the skeletal analgesic efficacy of different dosages of flunixin meglumine (FM). The objective of this experiment was to compare the efficacy of various dosages of FM with a negative control. The hypothesis was

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service